XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Deferred Compensation
Retained Earnings (Deficit)
Accumulated Other Comprehensive Loss
Treasury Stock
Beginning balance (in shares) at Jan. 29, 2022   13,964          
Beginning balance at Jan. 29, 2022 $ 225,472 $ 1,396 $ 160,348 $ 3,443 $ 77,914 $ (14,186) $ (3,443)
Beginning balance, treasury stock (in shares) at Jan. 29, 2022             (61)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of stock awards (in shares)   279          
Vesting of stock awards 0 $ 28 (28)        
Stock-based compensation expense 19,055   19,055        
Purchase and retirement of common stock (in shares)   (1,581)          
Purchase and retirement of common stock (78,913) $ (158) (30,829)   (47,926)    
Other comprehensive loss (2,825)         (2,825)  
Deferral of common stock into deferred compensation plan 0     218     $ (218)
Deferral of common stock into deferred compensation plan (in shares)             (4)
Net income (loss) $ 49,387       49,387    
Ending balance (in shares) at Oct. 29, 2022 12,597 12,662          
Ending balance at Oct. 29, 2022 $ 212,176 $ 1,266 148,546 3,661 79,375 (17,011) $ (3,661)
Ending balance, treasury stock (in shares) at Oct. 29, 2022 (65)           (65)
Beginning balance (in shares) at Jul. 30, 2022   13,087          
Beginning balance at Jul. 30, 2022 $ 184,181 $ 1,309 151,954 3,587 45,532 (14,614) $ (3,587)
Beginning balance, treasury stock (in shares) at Jul. 30, 2022             (64)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of stock awards (in shares)   9          
Vesting of stock awards 0 $ 1 (1)        
Stock-based compensation expense 5,221   5,221        
Purchase and retirement of common stock (in shares)   (434)          
Purchase and retirement of common stock (17,684) $ (44) (8,628)   (9,012)    
Other comprehensive loss (2,397)         (2,397)  
Deferral of common stock into deferred compensation plan 0     74     $ (74)
Deferral of common stock into deferred compensation plan (in shares)             (1)
Net income (loss) $ 42,855       42,855    
Ending balance (in shares) at Oct. 29, 2022 12,597 12,662          
Ending balance at Oct. 29, 2022 $ 212,176 $ 1,266 148,546 3,661 79,375 (17,011) $ (3,661)
Ending balance, treasury stock (in shares) at Oct. 29, 2022 (65)           (65)
Beginning balance (in shares) at Jan. 28, 2023 12,225 12,292          
Beginning balance at Jan. 28, 2023 $ 158,478 $ 1,229 150,956 3,736 22,540 (16,247) $ (3,736)
Beginning balance, treasury stock (in shares) at Jan. 28, 2023 (67)           (67)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of stock awards (in shares)   462          
Vesting of stock awards $ 0 $ 47 (47)        
Stock-based compensation benefit (6,424)   (6,424)        
Purchase and retirement of common stock (in shares)   (205)          
Purchase and retirement of common stock (7,026) $ (21) (4,155)   (2,850)    
Other comprehensive loss (1,252)         (1,252)  
Deferral of common stock into deferred compensation plan 0     196     $ (196)
Deferral of common stock into deferred compensation plan (in shares)             (6)
Net income (loss) $ (25,705)       (25,705)    
Ending balance (in shares) at Oct. 28, 2023 12,476 12,549          
Ending balance at Oct. 28, 2023 $ 118,071 $ 1,255 140,330 3,932 (6,015) (17,499) $ (3,932)
Ending balance, treasury stock (in shares) at Oct. 28, 2023 (73)           (73)
Beginning balance (in shares) at Jul. 29, 2023   12,544          
Beginning balance at Jul. 29, 2023 $ 85,930 $ 1,254 145,117 3,884 (44,477) (15,964) $ (3,884)
Beginning balance, treasury stock (in shares) at Jul. 29, 2023             (71)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of stock awards (in shares)   7          
Vesting of stock awards 0 $ 1 (1)        
Stock-based compensation benefit (4,746)   (4,746)        
Purchase and retirement of common stock (in shares)   (2)          
Purchase and retirement of common stock (60) $ 0 (40)   (20)    
Other comprehensive loss (1,535)         (1,535)  
Deferral of common stock into deferred compensation plan 0     48     $ (48)
Deferral of common stock into deferred compensation plan (in shares)             (2)
Net income (loss) $ 38,482       38,482    
Ending balance (in shares) at Oct. 28, 2023 12,476 12,549          
Ending balance at Oct. 28, 2023 $ 118,071 $ 1,255 $ 140,330 $ 3,932 $ (6,015) $ (17,499) $ (3,932)
Ending balance, treasury stock (in shares) at Oct. 28, 2023 (73)           (73)